Positive Identification of Kynurenine in Rat and Human Brain
The major degradative pathway in mammals for the essential amino acid tryptophan is initiated by oxidative cleavage of the pyrrole ring. The first readily detectable metabolite on this pathway is kynurenine. Its formation is measured in the assay in uitro of the liver enzyme catalysing this reaction, tryptophan pyrrolase (tryptophan 2,3-dioxygenase, EC 1.13.11.11), normally by monitoring A365 (Knox & Auerbach, 1955; Feigelson & Greengard, 1961) . Kynurenine determination in physiological fluids, sometimes after a tryptophan load, has been used as an index of tryptophan pyrrolase activity in vioo in man and animals (Price et al., 1965; Joseph et al., 1976) .
Limitations in the sensitivity and selectivity of current assays for kynurenine, and hence for the assay of tryptophan pyrrolase, prompted the development of a sensitive g.1.c. method for kynurenine (Naruse et af., 1973; Joseph 1977) . Indoleamine 2,3-dioxygenase (Hayaishi, 1976) catalyses the same reaction as tryptophan pyrrolase, but has a broader substrate specificity. It has been described in intestine and in a number of other tissues, including brain (Gal, 1974; Hayaishi, 1976) . The present communication describes the application of the new kynurenine assay to brain tissue.
Brain tissue was homogenized in 5vol. of acid butanol and back-extracted into 1 vol. of 0 . 1~-H C l as described by Curzon & Green (1970) . The 0.1 M-HCl phase was made alkaline with one-third of its volume of 1OM-NaOH, and Tiron (1,2-dihydroxybenzeneTime Fig. 1 . G.1.c. records from kynurenine analysis (a) 600ng of added kynurenine standard; (b) autopsied human brain cortex. Injection is indicated by arrow; the first major peak ( t = 6.4min) is dichloro-p-xylene internal standard, and the second ( t = 7.2) is the o-aminoacetophenone derivative. The graduations on the time scale represent 2min.
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3,5-disulphonic acid, disodium salt) added to a final concentration of 5 m~ (Joseph & Risby, 1975) . After extraction with butyl acetate it was heated in a boiling-water bath in a closed tube for 20min to cleave kynurenine to o-aminoacetophenone. After cooling, the o-aminoacetophenone was extracted into a small volume of butyl acetate containing 200 ng of ad-dichloro-p-xylene/ml as internal standard. The organic phase was mixed briefly with an equal volume of 0 . 2~-b o r a x in 1 ~M -N~O H , and the trifluoroacetamide derivative formed by adding one-eighth of the volume of trifluoroacetic anhydride, mixing immediately and centrifuging to separate the phases. A sample (1 PI) of supernatant was injected into a Hewlett-Packard 571 3A gas chromatograph [injection port 250"C, column 10% OVl on H.P. Chromosorb W a t 12OoC, detector 300°C 63Ni electron capture, carrier gas argon/methane (19 : 1) at 60ml/min.]
Standard kynurenine carried through this method yielded a single sharp symmetrical peak with a retention time of 7.2 min (Fig. la) . Peak height was linearly related to amount of standard kynurenine over the range 50ng-2pg of kynurenine added, the blank value corresponding to about 5ng. When the method was applied to brain tissue from male Sprague-Dawley rats (200-2508) a peak with the same retention time was observed. Recovery of kynurenine added to brain tissue was 80.3%. The rat brain content of kynurenine was determined to be 161f16ng/g (mean_+s.D., n = 7). Kynurenine was also measured in human brain at autopsy (Fig. lb) and was 317k 176(n = 8)ng/g in putamen and 216f 130(n = 8)ng/g in temporal cortex. However, smaller amounts, 162 and 200ng/g, were found in two samples from human temporal cortex, removed during therapeutic neurosurgery.
Many possible interfering substances have already been shown not to yield o-aminoacetophenone under these conditions (Joseph & Risby, 1975) . It was confirmed with the present technique that tryptophan at three times its normal concentration in brain does not interfere. Kynuramine also does not interfere, being removed by the first butyl acetate extraction (further examination of this fraction did not reveal any kynuramine in rat or human brain). The interference from acetylkynurenine observed previously (Joseph & Risby, 1975 ) is also found here, but is decreased from 26.3 to 5.7% by the acid butanol procedure. However, to confirm that the apparent kynurenine was not due to much larger amounts of acetylkynurenine, and to identify the kynurenine positively, mass spectrometry was combined with a scaled-down version of the column technique of Brown & Price (1956) . Whole rat brain or autopsied human brain cortex (log) were processed by scaling up the acid butanol procedure described. The 0.1 M-HCI extract obtained from this was applied t o 1 Scm-high columns of Dowex 50W (200-400 mesh), previously washed as described by Price et al. (1965) , contained in Pasteur pipettes. The columns were washed successively with 2ml portions of O~M -, OM-, 2 . 4~-, 5 . 0~-and ~.OM-HCI. These fractions were neutralized, then made alkaline and analysed for kynurenine as described above, with the omission of the first butyl acetate wash. The clear separation of acetyl-kynurenine and kynurenine is shown in the elution profiles in Figs. 2(b) and 2(c). The profiles observed for human and rat brain extracts in Figs. 2(d) and 2(e) correspond to that for kynurenine. The fifth fraction from the human and rat brain extracts, and also from standard kynurenine (applied to a column in the same way) were analysed on a Varian MAT-73 1 mass spectrometer by using gas-chromatographic introduction (accelerating voltage 8 kV; ionization energy 70eV, scan rate 2s/decade) and the results processed by the Varian SpectroSystem 100 MS.
The mass spectra obtained from human and rat brain (Figs. 2dand 2e) were essentially identical with the spectra from standard kynurenine carried through the method (Fig. 2c) and from authentic o-aminoacetophenone introduced at the stage of derivative formation (Fig. 2a) . They also agreed well with the mass spectrum of the o-aminoacetophenone derivative presented by Naruse et a [. (1973) . Thus there is a substance present in rat and human brain that gives rise to positively identifiable o-aminoacetophenone under conditions in which kynurenine does so, and behaves as kynurenine on a column before analysis.
These results demonstrate that kynurenine is present in rat and human brain and, in view of the demonstration of the necessary enzyme in rat brain (Gal, 1974) , make it (d) , (e) column elution patterns and mass spectra of derivative from fraction no. 5 for standard kynurenine, human brain extract and rat brain extract respectively. Vol. 6 likely that kynurenine is indeed synthesized from tryptophan within the brain. The assay method described should be useful both in the study of tryptophan and kynurenine metabolism in viuo, and in the assay in vitro of tryptophan pyrrolase and indolamine 2,3-dioxygenase.
The formation of acetoacetate directly from acetoacetyl-CoA was first demonstrated by Stern & Miller (1959) (1968) also demonstrated the presence of acetoacetyl-CoA deacylase in rat liver homogenates and reported that the major portion of the activity was cytosolic. However, Burch & Wertheim (1973) have shown that rat liver acetoacetyl-CoA deacylase is distributed in both the mitochondrial and cytosolic compartments, the mitochondria1 activity forming 60% of the total rat liver deacylase activity. The existence of a mitochondria1 acetoacetyl-CoA deacylase in human adipose tissue has been reported, and the possible importance of acetoacetate in fatty acid synthesis in this tissue discussed (Rous, 1976) . The present communication presents data on the subcellular distribution of rat brain acetoacetylCoA deacylase and its possible role in the brain cytosolic biosynthetic processes.
Rats used were of the Wistar strain. The brains of these animals were removed after decapitation; only the forebrain without the olfactory bulbs was used.
Acetoacetyl-CoA deacylase was assayed by the method of Williamson et al. (1968) . The rate of disappearance of acetoacetyl-CoA in the presence of iodoacetamide was monitored at 303nm, with 373nm as the reference wavelength on an Aminco-Chance dual-wavelength spectrophotometer in a dual-wavelength mode. Citrate synthase (EC 4.1.3.7) was assayed by the method of Coore et al. (1971) . Lactate dehydrogenase was measured by the method of Clark & Nicklas (1970) . The microsomal marker NADPH-cytochrome c reductase (rotenone-insensitive) (EC 1.6.99.2) was assayed by the method of Duncan & Mackler (1966) . Table 1 shows the specific activities, relative specific activities and percentage activities of all enzymes assayed in the various fractions. The total recovery of all enzyme activities was in excess of 90%, except for lactate dehydrogenase (total recovery 86.1 %).
